These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31177342)

  • 21. Association between mammographic breast density and breast cancer tumor characteristics.
    Aiello EJ; Buist DS; White E; Porter PL
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):662-8. PubMed ID: 15767347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.
    Malkov S; Shepherd JA; Scott CG; Tamimi RM; Ma L; Bertrand KA; Couch F; Jensen MR; Mahmoudzadeh AP; Fan B; Norman A; Brandt KR; Pankratz VS; Vachon CM; Kerlikowske K
    Breast Cancer Res; 2016 Dec; 18(1):122. PubMed ID: 27923387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volumetric breast density affects performance of digital screening mammography.
    Wanders JO; Holland K; Veldhuis WB; Mann RM; Pijnappel RM; Peeters PH; van Gils CH; Karssemeijer N
    Breast Cancer Res Treat; 2017 Feb; 162(1):95-103. PubMed ID: 28012087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
    Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
    AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study.
    Knight JA; Blackmore KM; Fan J; Malone KE; John EM; Lynch CF; Vachon CM; Bernstein L; Brooks JD; Reiner AS; Liang X; Woods M; ; Bernstein JL
    Breast Cancer Res; 2018 Mar; 20(1):23. PubMed ID: 29566728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early life socioeconomic environment and mammographic breast density.
    Tehranifar P; Cohn BA; Flom JD; Protacio A; Cirillo P; Lumey LH; Michels KB; Terry MB
    BMC Cancer; 2017 Jan; 17(1):41. PubMed ID: 28068940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy.
    Hada M; Oh H; Pfeiffer RM; Falk RT; Fan S; Mullooly M; Pollak M; Geller B; Vacek PM; Weaver D; Shepherd J; Wang J; Fan B; Mahmoudzadeh AP; Malkov S; Herschorn S; Brinton LA; Sherman ME; Gierach GL
    Breast Cancer Res; 2019 Jul; 21(1):81. PubMed ID: 31337427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is mammographic density a marker of breast cancer phenotypes?
    Kanbayti IH; Rae WID; McEntee MF; Al-Foheidi M; Ashour S; Turson SA; Ekpo EU
    Cancer Causes Control; 2020 Aug; 31(8):749-765. PubMed ID: 32410205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular comparison of interval and screen-detected breast cancers.
    Cheasley D; Li N; Rowley SM; Elder K; Mann GB; Loi S; Savas P; Goode DL; Kader T; Zethoven M; Semple T; Fox SB; Pang JM; Byrne D; Devereux L; Nickson C; Procopio P; Lee G; Hughes S; Saunders H; Fujihara KM; Kuykhoven K; Connaughton J; James PA; Gorringe KL; Campbell IG
    J Pathol; 2019 Jun; 248(2):243-252. PubMed ID: 30746706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
    Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
    Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transverse relaxation-based assessment of mammographic density and breast tissue composition by single-sided portable NMR.
    Ali TS; Tourell MC; Hugo HJ; Pyke C; Yang S; Lloyd T; Thompson EW; Momot KI
    Magn Reson Med; 2019 Sep; 82(3):1199-1213. PubMed ID: 31034648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype.
    Shieh Y; Scott CG; Jensen MR; Norman AD; Bertrand KA; Pankratz VS; Brandt KR; Visscher DW; Shepherd JA; Tamimi RM; Vachon CM; Kerlikowske K
    Breast Cancer Res; 2019 Apr; 21(1):48. PubMed ID: 30944014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammographic density and breast cancer in women from high risk families.
    Ramón Y Cajal T; Chirivella I; Miranda J; Teule A; Izquierdo Á; Balmaña J; Sánchez-Heras AB; Llort G; Fisas D; Lope V; Hernández-Agudo E; Juan-Fita MJ; Tena I; Robles L; Guillén-Ponce C; Pérez-Segura P; Luque-Molina MS; Hernando-Polo S; Salinas M; Brunet J; Salas-Trejo MD; Barnadas A; Pollán M
    Breast Cancer Res; 2015 Jul; 17(1):93. PubMed ID: 26163143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer.
    Duffy SW; Morrish OWE; Allgood PC; Black R; Gillan MGC; Willsher P; Cooke J; Duncan KA; Michell MJ; Dobson HM; Maroni R; Lim YY; Purushothaman HN; Suaris T; Astley SM; Young KC; Tucker L; Gilbert FJ
    Eur J Cancer; 2018 Jan; 88():48-56. PubMed ID: 29190506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis.
    Holm J; Li J; Darabi H; Eklund M; Eriksson M; Humphreys K; Hall P; Czene K
    J Clin Oncol; 2016 Jan; 34(3):251-8. PubMed ID: 26628467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
    Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
    Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: associations with survival.
    Lo Gullo R; Daimiel I; Rossi Saccarelli C; Bitencourt A; Sevilimedu V; Martinez DF; Jochelson MS; Morris EA; Reiner JS; Pinker K
    Breast Cancer Res; 2020 Aug; 22(1):93. PubMed ID: 32819432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and tumour characteristics of bilateral and unilateral interval breast cancers at screening mammography.
    van Bommel RMG; Voogd AC; Nederend J; Setz-Pels W; Louwman MWJ; Strobbe LJ; Venderink D; Tjan-Heijnen VCG; Duijm LEM
    Breast; 2018 Apr; 38():101-106. PubMed ID: 29306176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammographic density changes following BC treatment.
    Kanbayti IH; Rae WID; McEntee MF; Ekpo EU
    Clin Imaging; 2021 Aug; 76():88-97. PubMed ID: 33578136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.